Semaglutide Brand Names: Ozempic, Wegovy & Rybelsus

Quick Answer: Semaglutide is the active drug ingredient sold under three FDA-approved semaglutide brand names: Ozempic (injection for type 2 diabetes), Wegovy (injection for weight loss and obesity), and Rybelsus (oral tablet for type 2 diabetes). All three are made by Novo Nordisk and work the same way — but each semaglutide brand name has a different approved use, dose, and price.

Key Takeaways

• 🔵 Ozempic is FDA-approved for type 2 diabetes management and reducing cardiovascular risk, given as a weekly injection.
• 🟢 Wegovy is FDA-approved for chronic weight management in adults and children 12+ with obesity, also a weekly injection at a higher dose.
• 🟠 Rybelsus is the only oral semaglutide currently available in the US, approved for type 2 diabetes.
• 💊 A new Ozempic Pill is expected to launch in the US in Q2 2026, which will replace Rybelsus as the oral option. [1]
• 💰 Starting January 1, 2027, Novo Nordisk plans to reduce the list price of all three brands to $675/month, roughly a 50% cut for Wegovy and 35% for Ozempic and Rybelsus. [2]
• ⚠️ An emerging safety concern — NAION (a serious vision loss condition) — is not yet listed on drug labels as of early 2026, despite published research linking semaglutide to elevated risk. [1]
• 🚫 You cannot combine any two semaglutide brand names at the same time — doing so is contraindicated. [2]
• 📋 All three brands share common side effects: nausea, diarrhea, vomiting, and gallbladder problems. [2]

What Is Semaglutide and Why Does It Have Multiple Brand Names?

Semaglutide is a GLP-1 receptor agonist — a drug that mimics a natural gut hormone to lower blood sugar, reduce appetite, and slow digestion. Novo Nordisk developed it and brought it to market under different brand names because the FDA approves drugs for specific conditions and doses, not just the molecule itself.

So the same compound, semaglutide, gets a different name, dose, and label depending on what it’s prescribed for:

• Ozempic = lower doses for blood sugar control in type 2 diabetes
• Wegovy = higher doses for weight loss
• Rybelsus = oral tablets for type 2 diabetes

This matters because your insurance coverage, co-pay, and prescription eligibility all depend on which semaglutide brand name your doctor writes on the prescription — not just the drug itself.

For a broader comparison of GLP-1 options, see our guide on the best GLP-1 medications approved for weight loss.

Ozempic: The Semaglutide Brand Name for Type 2 Diabetes

Ozempic is a weekly subcutaneous injection approved for adults with type 2 diabetes. It’s also approved to reduce the risk of major cardiovascular events (heart attack, stroke) in adults with type 2 diabetes and known heart disease, and to slow kidney disease progression in adults with type 2 diabetes and chronic kidney disease. [2]

Ozempic Doses and How It Works

Ozempic comes in three injection doses: 0.5 mg, 1 mg, and 2 mg per week. Patients typically start at 0.25 mg for the first four weeks to reduce side effects, then step up to the maintenance dose their doctor recommends.

Feature	Ozempic
Active ingredient	Semaglutide
Form	Weekly subcutaneous injection
FDA-approved for	Type 2 diabetes, cardiovascular risk reduction, CKD
Available doses	0.5 mg, 1 mg, 2 mg weekly
Current list price (2026)	~$1,000/month
New list price (Jan 2027)	$675/month [2]

Common mistake: Many people ask their doctor for Ozempic specifically for weight loss. Ozempic is not FDA-approved for weight loss — that’s Wegovy’s job. Using Ozempic off-label for weight loss can create insurance coverage problems and may not be covered.

Wegovy: The Semaglutide Brand Name for Weight Loss

Wegovy is FDA-approved for chronic weight management in adults and adolescents 12 and older with obesity or overweight with at least one weight-related condition (such as high blood pressure, high cholesterol, or type 2 diabetes). [2]

It’s the same molecule as Ozempic, but at a higher weekly dose — 2.4 mg — which is the dose shown in clinical trials to produce meaningful weight loss when combined with diet and exercise.

Who Qualifies for Wegovy?

• Adults with a BMI of 30 or higher (obesity)
• Adults with a BMI of 27 or higher plus at least one weight-related health condition
• Children 12 and older with obesity (BMI at or above the 95th percentile for age and sex), using doses of 1.7 mg or 2.4 mg [2]

Feature	Wegovy
Active ingredient	Semaglutide
Form	Weekly subcutaneous injection
FDA-approved for	Obesity, overweight with comorbidities, cardiovascular risk
Available doses	0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg (titration)
Current list price (2026)	~$1,350/month
New list price (Jan 2027)	$675/month [2]

If you’re comparing Wegovy to other weight loss injections, our semaglutide weight loss injections guide breaks down what to expect at each stage of treatment.

Choose Wegovy if: Your primary goal is weight loss and you meet the BMI criteria above. Your insurance is more likely to cover it under an obesity treatment benefit than Ozempic.

Rybelsus: The Oral Semaglutide Brand Name

Rybelsus is the only FDA-approved oral semaglutide currently available in the US. It comes as a daily tablet (7 mg or 14 mg) and is approved for adults with type 2 diabetes to improve blood sugar control. It is not approved for weight loss. [2]

Taking Rybelsus correctly matters more than with the injections. It must be taken on an empty stomach with no more than 4 ounces of plain water, at least 30 minutes before eating, drinking anything else, or taking other oral medications.

What’s Changing With Rybelsus in 2026?

Novo Nordisk announced in February 2026 that an Ozempic Pill will launch in the US in Q2 2026, which is expected to replace Rybelsus as the oral semaglutide option. [1] As of this writing, Rybelsus is still available, but patients and prescribers should watch for updates on this transition.

For a deeper look at how oral semaglutide tablets perform in real-world use, see our semaglutide tablets reviews.

The 3 Most Affordable GLP 1 Without Insurance “TrumpRX (2026 Ranked)

🥇 #1 Best Overall: Zepbound (Triple-Action Option)

DirectMeds is a LegitScript-certified telehealth platform that connects patients with licensed U.S. physicians who evaluate whether compounded GLP-1 medications are clinically appropriate.

It is one of the most established providers in this space and is particularly well-suited to patients who want high-touch clinical oversight without paying brand-name prices.

How it works: Complete a secure online health intake form. A licensed medical provider reviews your profile and determines eligibility. If approved, your prescription is sent to a certified U.S. compounding pharmacy and medication is shipped directly to your door. All-inclusive pricing covers medical consultation, medication, and 24/7 support — no surprise charges.

◉ Clinical Note: DirectMeds’ LegitScript certification is a meaningful differentiator in this market. It requires compliance with pharmacy laws, prescription standards, and advertising guidelines — reducing the risk of receiving substandard compounded medications. For patients new to telehealth GLP-1 programs, this certification provides a meaningful layer of accountability. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients who want an established, verified provider with strong clinical support and are comfortable paying slightly more than the absolute floor price for greater peace of mind.

🥈#2 Best for Long-Term Cost Certainty: MyStart GLP-1

🥈 Silver Standard — Best Flat-Rate Pricing

👉 Check MyStart Eligibilit→

MyStart GLP-1 uses a unique flat-rate membership model where your medication cost is fixed regardless of how high your therapeutic dose increases over time. For patients who will be on GLP-1 therapy for 12 months or more, this pricing structure can save $600 to $1,800 annually compared to platforms that charge progressively more as doses escalate.

How it works: Pay a monthly membership ($79) plus a flat medication fee (e.g., $175 for compounded semaglutide). The combined total stays fixed at $254 per month from starter dose through maximum maintenance dose. Medical consultation, all medication, dedicated care team access, and nutritional coaching are included.

◉ Clinical Note: The flat-rate model is financially sound for long-term GLP-1 use. GLP-1 therapy is most effective when sustained for 12+ months, and avoiding dose-related price increases removes a common reason patients discontinue treatment early. The included nutritional coaching adds meaningful clinical value, as sustainable weight loss requires both medication and lifestyle change. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients committed to long-term treatment (12+ months) who want price certainty as doses increase, and who value behavioral coaching as part of their program.

Best for: People who want a more advanced GLP-1 approach at a reduced price. 👉 SKIP THE WAITLIST. START FOR $199

Thousands of people are losing weight with MyStart GLP-1 medications. People like you are transforming their lives, feeling better, and looking their best with the help of GLP-1 (Dual-Action Option) medications.

🥉 #3 Best for Absolute Lowest Entry Cost: MEDVi GLP-1

🥉 Bronze Standard — Lowest Entry Price

👉 Check MEDVi Eligibility→

MEDVi offers the most accessible entry price point in the compounded GLP-1 market, with starter doses beginning as low as $99 per month and a published price-match guarantee.

The platform provides both injectable and oral compounded GLP-1 options, giving prescribers flexibility to match the medication form to the patient. Clinical follow-up is primarily quarterly rather than monthly, which keeps costs lower but means less frequent dose adjustment guidance than the two options above.

How it works: Complete an online consultation. If qualified, your prescription is sent to a partner compounding pharmacy and medication is shipped to you within 48 hours. Customer support is available, and clinical check-ins are typically quarterly. No membership fees are charged on top of medication pricing.

◉ Clinical Note: MEDVi is a legitimate, cost-effective option for budget-focused patients who have researched compounded medications and are comfortable with less frequent clinical contact. Always ask your provider which specific compounding pharmacy fulfills your prescription — a reputable 503A or 503B state-licensed pharmacy is non-negotiable for safety. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Budget-focused patients who have done their research on compounded GLP-1 medications, are comfortable managing more of their own care independently, and want the lowest possible entry price with a price-match guarantee.

👉 START LOSING FOR $200 TODAY

How Do the Three Semaglutide Brand Names Compare?

Here’s a side-by-side view of all three brands to help you and your doctor make the right call:

	Ozempic	Wegovy	Rybelsus
Form	Injection (weekly)	Injection (weekly)	Tablet (daily)
Approved use	Type 2 diabetes, CV risk, CKD	Obesity / weight loss	Type 2 diabetes
Max dose	2 mg/week	2.4 mg/week	14 mg/day
Pediatric use	No	Yes (12+)	No
2026 list price	~$1,000/mo	~$1,350/mo	~$1,000/mo
2027 planned price	$675/mo [3]	$675/mo [3]	$675/mo [3]

All three share the same active ingredient and the same core mechanism. The differences are dose, delivery method, and FDA-approved indication.

If you’re weighing semaglutide against tirzepatide (the active ingredient in Mounjaro and Zepbound), our semaglutide vs tirzepatide comparison covers the key clinical differences.

What Are the Side Effects Across All Semaglutide Brand Names?

All three semaglutide brands share a similar side effect profile because they contain the same active ingredient. The most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and stomach pain — and they’re usually worst during dose increases. [2]

Common Side Effects (All Three Brands)

• Nausea, diarrhea, vomiting
• Constipation, stomach pain, bloating, gas
• Headache, fatigue, dizziness
• Low blood sugar (especially when combined with insulin or sulfonylureas)
• Heartburn, upset stomach, belching
• Runny nose or sore throat [2]

Serious Warnings to Know

• Gallbladder problems: All three brands carry warnings for gallstones, some requiring surgery. Watch for upper abdominal pain, fever, or jaundice. [2]
• NAION (vision loss): Medical literature published since July 2024 links semaglutide to a roughly 2x higher risk of NAION (non-arteritic anterior ischemic optic neuropathy) compared to SGLT2 inhibitor diabetes drugs. As of February 2026, this risk is not listed on the drug label for Ozempic or Rybelsus. Multiple lawsuits have been filed against Novo Nordisk over this issue. [1]
• Thyroid tumors: All three brands carry a boxed warning about a potential risk of thyroid C-cell tumors based on animal studies.
• Pancreatitis: Discontinue immediately if pancreatitis is suspected.

⚠️ Important: If you notice sudden vision changes while taking any semaglutide brand name, contact your doctor immediately and mention the NAION risk. Ask your prescriber directly about this concern, since it is not currently on the label. [1]

---

What Does Each Semaglutide Brand Name Cost in 2026?

Cost is one of the biggest barriers to semaglutide access. In 2026, list prices remain high — around $1,000/month for Ozempic and Rybelsus, and approximately $1,350/month for Wegovy — but significant changes are coming.

Planned Price Reduction Starting January 1, 2027

Novo Nordisk has announced it will reduce the US list price for all three semaglutide brands to $675 per month, effective January 1, 2027. This applies to all doses of each brand. [2][3] That’s roughly:

• ~50% reduction for Wegovy
• ~35% reduction for Ozempic and Rybelsus

This is the list price — what you’d pay without insurance. With insurance, your actual cost depends on your plan’s formulary and coverage tier.

Ways to Reduce Your Cost Right Now

• Manufacturer savings cards: Novo Nordisk offers savings programs for eligible commercially insured patients.
• Telehealth GLP-1 programs: Several direct-pay telehealth services offer compounded or brand-name semaglutide at lower monthly costs.
• GoodRx and coupon programs: Can reduce out-of-pocket costs at certain pharmacies.

For current pricing options, see our guide on semaglutide without insurance cost and our breakdown of affordable GLP-1 options without insurance.

Which Semaglutide Brand Name Is Right for You?

The right semaglutide brand name depends on your diagnosis, your primary treatment goal, and your insurance coverage. Here’s a simple decision framework:

• Choose Ozempic if: You have type 2 diabetes, your doctor wants to lower your A1C, and/or you have cardiovascular disease or chronic kidney disease. Weight loss may occur as a secondary benefit.
• Choose Wegovy if: Your primary goal is weight loss or obesity treatment. You meet the BMI criteria. You want the highest FDA-approved dose of semaglutide.
• Choose Rybelsus if: You have type 2 diabetes and strongly prefer an oral pill over injections. Note the strict morning dosing requirements.
• Watch for the Ozempic Pill (Q2 2026): If you want an oral option and are open to waiting, this new formulation may offer a simpler alternative to Rybelsus. [1]

Edge case: If you’re already on one semaglutide brand name, you cannot add another. Combining any two semaglutide products is contraindicated. [2]

For guidance on what to eat while on any of these medications, our GLP-1 diet guide covers the best foods to maximize results and minimize side effects.

Frequently Asked Questions

Is Ozempic the same as Wegovy?

Both contain semaglutide, but they are not the same product. Ozempic is approved for type 2 diabetes at doses up to 2 mg/week. Wegovy is approved for obesity at doses up to 2.4 mg/week. Different indications, different doses, different insurance coverage.

Can I use Ozempic for weight loss?

Ozempic is not FDA-approved for weight loss. Some doctors prescribe it off-label for that purpose, but insurance typically won’t cover it for weight loss. Wegovy is the correct on-label choice for obesity treatment.

What is the semaglutide brand name for the oral pill?

Currently, Rybelsus is the only FDA-approved oral semaglutide in the US. An Ozempic Pill is expected to launch in Q2 2026 and may replace Rybelsus. [1]

Will semaglutide prices drop in 2026?

The major price reduction — to $675/month for all three brands — is planned for January 1, 2027, not 2026. Current 2026 list prices remain around $1,000–$1,350/month. [2][3]

Are all semaglutide brand names made by the same company?

Yes. Ozempic, Wegovy, and Rybelsus are all manufactured and marketed by Novo Nordisk.

Can children take semaglutide?

Wegovy (1.7 mg or 2.4 mg) is FDA-approved for children 12 years and older with obesity. Ozempic and Rybelsus are not approved for pediatric use. [2]

What is NAION and should I be worried?

NAION is a type of vision loss caused by reduced blood flow to the optic nerve. Research since 2024 suggests semaglutide may roughly double the risk compared to certain other diabetes drugs. As of early 2026, this warning is not on the drug label. Talk to your doctor if you notice any vision changes. [1]

Can I take two semaglutide brands at once?

No. Combining any two semaglutide-containing products or any two GLP-1 receptor agonists is contraindicated and should not be done. [2]

Is compounded semaglutide the same as brand-name semaglutide?

Compounded semaglutide is not FDA-approved and is not identical to the brand-name products. Quality and dosing can vary. See our best semaglutide for fat loss guide for a breakdown of your options.

How long does it take to see results on semaglutide?

Most people notice appetite changes within the first few weeks. Meaningful weight loss typically becomes visible by weeks 8–12 on Wegovy. For a realistic timeline, see our 6-week Ozempic weight loss results guide.

Conclusion

Understanding each semaglutide brand name is the first step to getting the right treatment. Ozempic, Wegovy, and Rybelsus all contain the same active drug — but they serve different purposes, come in different doses, and carry different price tags and insurance implications.

Here’s what to do next:

1. Clarify your goal with your doctor: blood sugar control, weight loss, or both.
2. Ask specifically which semaglutide brand name is FDA-approved for your condition.
3. Discuss the NAION risk with your prescriber — especially if you have any pre-existing eye conditions. [1]
4. Check your insurance formulary before filling a prescription — coverage varies significantly between Ozempic and Wegovy even though they’re the same molecule.
5. Plan for 2027 pricing if cost is a barrier right now. The $675/month list price takes effect January 1, 2027. [2]
6. Watch for the Ozempic Pill launch in Q2 2026 if you prefer oral medication over injections. [1]

The right semaglutide brand name, at the right dose, for the right diagnosis — that’s the combination that leads to real results.

References

[1] Semaglutide NAION Risk Ozempic Pills 2026 – https://drug-injury.com/2026/03/02/semaglutide-naion-risk-ozempic-pills-2026/

[2] Novo Nordisk Announces Significant Reduction in US List Price for Wegovy, Ozempic and Rybelsus Semaglutide Medicines – https://www.prnewswire.com/news-releases/novo-nordisk-announces-significant-reduction-in-us-list-price-for-wegovy-ozempic-and-rybelsus-semaglutide-medicines-building-on-continued-efforts-to-expand-access-302695705.html

[3] Novo Nordisk Wegovy Ozempic Rybelsus $675 2027 – https://fyh.news/novo-nordisk-wegovy-ozempic-rybelsus-675-2027/

[4] Novo Nordisk Announces Significant Reduction in US List Price for Wegovy, Ozempic and Rybelsus – https://www.pharmalive.com/novo-nordisk-announces-significant-reduction-in-u-s-list-price-for-wegovy-ozempic-and-rybelsus/